BIOVORN LIMITED

EC4A 3DW (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£69,969

Nov 18 - Oct 19

SPX - Novel Mastitis Treatment

Innovate UK award to BIOVORN LIMITED and Jerome Vaughan

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}